Bob-1 specific peptides and T-cells
The invention describes a method to identify T-cells (CTL, CD4+ T-helper), which are specifically directed to or have a highly specific cross-reactivity with Bob-1 derived peptides presented by HLA molecules on the cell surface of Bob-1 expressing cells.
Further Information: PDF
Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V.
Phone: +49 (0)89/1205-6000
Contact
Dr. Wolfgang Knappe
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Recharging the Future: Batteries Built for Extreme Cold Using Negative Thermal Expansion
Most solids expand as temperatures increase and shrink as they cool. Some materials do the opposite, expanding in the cold. Lithium titanium phosphate is one such substance and could provide…
Self-Destructing Cancer Cells: Cutting-Edge RNA Breakthrough
Jülich scientists use novel RNA technology to selectively switch off tumours in the brain. An Adaptable Platform Technology That Destroys Glioblastoma Cancer Cells Using a special RNA molecule, a team…
Endurance Training: Transforming Lives of Heart Failure Patients
Can strength and endurance training be beneficial for patients with a certain form of heart failure? A research team from Greifswald investigated this question together with seven other research centers…